Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study
The aim of this study was to investigate the effect of levothyroxine (LT4) replacement therapy during three months on some parameters of metabolic syndrome and atherosclerosis in patients with increased thyroid-stimulating hormone (TSH) level. This study included a group of 30 female patients with T...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/147070 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552424763555840 |
|---|---|
| author | Zoran Gluvic Emina Sudar Jelena Tica Aleksandra Jovanovic Sonja Zafirovic Ratko Tomasevic Esma R. Isenovic |
| author_facet | Zoran Gluvic Emina Sudar Jelena Tica Aleksandra Jovanovic Sonja Zafirovic Ratko Tomasevic Esma R. Isenovic |
| author_sort | Zoran Gluvic |
| collection | DOAJ |
| description | The aim of this study was to investigate the effect of levothyroxine (LT4) replacement therapy during three months on some parameters of metabolic syndrome and atherosclerosis in patients with increased thyroid-stimulating hormone (TSH) level. This study included a group of 30 female patients with TSH level >4 mIU/L and 15 matched healthy controls. Intima media complex thickness (IMCT) and peak systolic flow velocity (PSFV) of superficial femoral artery were determined by Color Doppler scan. In hypothyroid subjects, BMI, SBP, DBP, and TSH were significantly increased versus controls and decreased after LT4 administration. FT4 was significantly lower in hypothyroid subjects compared with controls and significantly higher by treatment. TC, Tg, HDL-C, and LDL-C were similar to controls at baseline but TC and LDL-C were significantly decreased by LH4 treatment. IMCT was significantly increased versus controls at baseline and significantly reduced by treatment. PSFV was similar to controls at baseline and significantly decreased on treatment. In this study, we have demonstrated the effects of LT4 replacement therapy during three months of treatment on correction of risk factors of metabolic syndrome and atherosclerosis. |
| format | Article |
| id | doaj-art-486a46202f48405895a05b78ef7bbaad |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-486a46202f48405895a05b78ef7bbaad2025-02-03T05:58:39ZengWileyInternational Journal of Endocrinology1687-83371687-83452015-01-01201510.1155/2015/147070147070Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot StudyZoran Gluvic0Emina Sudar1Jelena Tica2Aleksandra Jovanovic3Sonja Zafirovic4Ratko Tomasevic5Esma R. Isenovic6Zemun Clinical Hospital, Vukova 9, 11080 Belgrade, SerbiaVinca Institute of Nuclear Sciences, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, P.O. Box 522, Mike Petrovica Alasa 12-14, 11001 Belgrade, SerbiaZemun Clinical Hospital, Vukova 9, 11080 Belgrade, SerbiaVinca Institute of Nuclear Sciences, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, P.O. Box 522, Mike Petrovica Alasa 12-14, 11001 Belgrade, SerbiaVinca Institute of Nuclear Sciences, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, P.O. Box 522, Mike Petrovica Alasa 12-14, 11001 Belgrade, SerbiaZemun Clinical Hospital, Vukova 9, 11080 Belgrade, SerbiaVinca Institute of Nuclear Sciences, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, P.O. Box 522, Mike Petrovica Alasa 12-14, 11001 Belgrade, SerbiaThe aim of this study was to investigate the effect of levothyroxine (LT4) replacement therapy during three months on some parameters of metabolic syndrome and atherosclerosis in patients with increased thyroid-stimulating hormone (TSH) level. This study included a group of 30 female patients with TSH level >4 mIU/L and 15 matched healthy controls. Intima media complex thickness (IMCT) and peak systolic flow velocity (PSFV) of superficial femoral artery were determined by Color Doppler scan. In hypothyroid subjects, BMI, SBP, DBP, and TSH were significantly increased versus controls and decreased after LT4 administration. FT4 was significantly lower in hypothyroid subjects compared with controls and significantly higher by treatment. TC, Tg, HDL-C, and LDL-C were similar to controls at baseline but TC and LDL-C were significantly decreased by LH4 treatment. IMCT was significantly increased versus controls at baseline and significantly reduced by treatment. PSFV was similar to controls at baseline and significantly decreased on treatment. In this study, we have demonstrated the effects of LT4 replacement therapy during three months of treatment on correction of risk factors of metabolic syndrome and atherosclerosis.http://dx.doi.org/10.1155/2015/147070 |
| spellingShingle | Zoran Gluvic Emina Sudar Jelena Tica Aleksandra Jovanovic Sonja Zafirovic Ratko Tomasevic Esma R. Isenovic Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study International Journal of Endocrinology |
| title | Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study |
| title_full | Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study |
| title_fullStr | Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study |
| title_full_unstemmed | Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study |
| title_short | Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot Study |
| title_sort | effects of levothyroxine replacement therapy on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients a prospective pilot study |
| url | http://dx.doi.org/10.1155/2015/147070 |
| work_keys_str_mv | AT zorangluvic effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy AT eminasudar effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy AT jelenatica effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy AT aleksandrajovanovic effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy AT sonjazafirovic effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy AT ratkotomasevic effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy AT esmarisenovic effectsoflevothyroxinereplacementtherapyonparametersofmetabolicsyndromeandatherosclerosisinhypothyroidpatientsaprospectivepilotstudy |